$43.73
-1.07-2.39%
At Close: -
$43.73
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Lazard
LAZNYSE
Lazard (NYSE:LAZ) Stock, Analyst Ratings, Price Targets, Forecasts
Lazard Inc has a consensus price target of $43.78 based on the ratings of 10 analysts. The high is $54 issued by Morgan Stanley on June 21, 2024. The low is $29 issued by Morgan Stanley on October 31, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, Keefe, Bruyette & Woods, and Morgan Stanley on June 21, 2024, April 26, 2024, and April 11, 2024, respectively. With an average price target of $53.67 between Morgan Stanley, Keefe, Bruyette & Woods, and Morgan Stanley, there's an implied 22.72% upside for Lazard Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Keefe, Bruyette & Woods
UBS
Keefe, Bruyette & Woods
Wolfe Research
1calculated from analyst ratings
Analyst Ratings for Lazard
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/21/2024 | Buy Now | 23.49% | Morgan Stanley | Ryan Kenny | $58 → $54 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 12.05% | Keefe, Bruyette & Woods | Aidan Hall | $51 → $49 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2024 | Buy Now | 32.63% | Morgan Stanley | Ryan Kenny | → $58 | Maintains | Overweight | Get Alert |
| 03/26/2024 | Buy Now | 0.62% | UBS | Brennan Hawken | $43 → $44 | Maintains | Neutral | Get Alert |
| 02/05/2024 | Buy Now | -1.67% | UBS | Brennan Hawken | $40 → $43 | Maintains | Neutral | Get Alert |
| 01/29/2024 | Buy Now | 16.62% | Keefe, Bruyette & Woods | Michael Brown | → $51 | Reinstates | → Outperform | Get Alert |
| 01/09/2024 | Buy Now | -8.53% | UBS | Brennan Hawken | $31 → $40 | Maintains | Neutral | Get Alert |
| 01/03/2024 | Buy Now | -3.96% | Wolfe Research | Steven Chubak | → $42 | Upgrade | Peer Perform → Outperform | Get Alert |
| 12/19/2023 | Buy Now | -29.11% | Goldman Sachs | Richard Ramsden | $28 → $31 | Maintains | Sell | Get Alert |
| 10/27/2023 | Buy Now | 2.9% | Morgan Stanley | Ryan Kenny | $41 → $45 | Maintains | Overweight | Get Alert |
| 10/12/2023 | Buy Now | -6.24% | Morgan Stanley | Ryan Kenny | $42 → $41 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | 14.34% | JMP Securities | Devin Ryan | $53 → $50 | Maintains | Market Outperform | Get Alert |
| 10/03/2023 | Buy Now | -26.82% | UBS | Brennan Hawken | $37 → $32 | Maintains | Neutral | Get Alert |
| 09/26/2023 | Buy Now | -3.96% | Morgan Stanley | Ryan Kenny | $44 → $42 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | -26.82% | Goldman Sachs | Richard Ramsden | $37 → $32 | Downgrade | Neutral → Sell | Get Alert |
| 07/31/2023 | Buy Now | -15.39% | UBS | Brennan Hawken | $32 → $37 | Maintains | Neutral | Get Alert |
| 07/14/2023 | Buy Now | -1.67% | Morgan Stanley | Ryan Kenny | $43 → $43 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | — | Keefe, Bruyette & Woods | Matthew Moon | — | Upgrade | Underperform → Market Perform | Get Alert |
| 07/12/2023 | Buy Now | -1.67% | Morgan Stanley | Ryan Kenny | $36 → $43 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/10/2023 | Buy Now | 21.2% | JMP Securities | Devin Ryan | → $53 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/03/2023 | Buy Now | — | Wolfe Research | Steven Chubak | — | Upgrade | Underperform → Peer Perform | Get Alert |
| 05/22/2023 | Buy Now | 21.2% | JMP Securities | Devin Ryan | $53 → $53 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/01/2023 | Buy Now | -29.11% | Keefe, Bruyette & Woods | Matthew Moon | $34 → $31 | Maintains | Underperform | Get Alert |
| 04/12/2023 | Buy Now | -17.68% | Morgan Stanley | Ryan Kenny | $29 → $36 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/10/2023 | Buy Now | 21.2% | JMP Securities | Devin Ryan | $56 → $53 | Maintains | Market Outperform | Get Alert |
| 10/31/2022 | Buy Now | -33.68% | Morgan Stanley | Manan Gosalia | $28 → $29 | Maintains | Underweight | Get Alert |
| 08/04/2022 | Buy Now | -17.68% | Goldman Sachs | Richard Ramsden | $32 → $36 | Maintains | Neutral | Get Alert |
| 07/18/2022 | Buy Now | -31.4% | Morgan Stanley | Manan Gosalia | $40 → $30 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/13/2022 | Buy Now | -31.4% | Keefe, Bruyette & Woods | Michael Brown | $38 → $30 | Downgrade | Market Perform → Underperform | Get Alert |
| 07/08/2022 | Buy Now | 0.62% | Piper Sandler | Jeffery Harte | $45 → $44 | Maintains | Overweight | Get Alert |
| 04/07/2022 | Buy Now | 2.9% | Piper Sandler | Jeffery Harte | $49 → $45 | Maintains | Overweight | Get Alert |
| 04/07/2022 | Buy Now | 28.06% | JMP Securities | Devin Ryan | $58 → $56 | Maintains | Market Outperform | Get Alert |
| 04/07/2022 | Buy Now | -10.82% | Wolfe Research | Steven Chubak | → $39 | Downgrade | Peer Perform → Underperform | Get Alert |
| 03/09/2022 | Buy Now | 18.91% | Piper Sandler | Jeffery Harte | $62 → $52 | Maintains | Overweight | Get Alert |
| 03/08/2022 | Buy Now | -8.53% | Morgan Stanley | Manan Gosalia | → $40 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/04/2022 | Buy Now | 12.05% | Keefe, Bruyette & Woods | Michael Brown | $52 → $49 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/04/2022 | Buy Now | -1.67% | UBS | Brennan Hawken | $47 → $43 | Maintains | Neutral | Get Alert |
| 12/08/2021 | Buy Now | 25.77% | Morgan Stanley | Manan Gosalia | — | Maintains | Overweight | Get Alert |
| 10/01/2021 | Buy Now | 32.63% | Keefe, Bruyette & Woods | Michael Brown | — | Upgrade | Market Perform → Outperform | Get Alert |
FAQ
What is the target price for Lazard (LAZ) stock?
The latest price target for Lazard (NYSE:LAZ) was reported by Morgan Stanley on June 21, 2024. The analyst firm set a price target for $54.00 expecting LAZ to rise to within 12 months (a possible 23.49% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lazard (LAZ)?
The latest analyst rating for Lazard (NYSE:LAZ) was provided by Morgan Stanley, and Lazard maintained their overweight rating.
When was the last upgrade for Lazard (LAZ)?
The last upgrade for Lazard Inc happened on January 3, 2024 when Wolfe Research raised their price target to $42. Wolfe Research previously had a peer perform for Lazard Inc.
When was the last downgrade for Lazard (LAZ)?
The last downgrade for Lazard Inc happened on September 19, 2023 when Goldman Sachs changed their price target from $37 to $32 for Lazard Inc.
When is the next analyst rating going to be posted or updated for Lazard (LAZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lazard, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lazard was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
Is the Analyst Rating Lazard (LAZ) correct?
While ratings are subjective and will change, the latest Lazard (LAZ) rating was a maintained with a price target of $58.00 to $54.00. The current price Lazard (LAZ) is trading at is $43.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.